Important notification
18.06.2024 To the attention of all Marketing Authorisation Holders / Legal representatives of Marketing Authorisation Holders As of 01.07.2024, temporary […]
Press release
14.06.2024 To the attention of interested persons Review of painkiller metamizole started download document …
Press release
12.06.2024 To the attention of interested persons Recommendations of the Executive Steering Group on Shortages and Safety of Medicinal Products […]
Important notification
12.06.2024 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]
Important notification
06.06.2024 To the attention of all Marketing Authorisation Holders / Legal representatives of Marketing Authorisation Holders Please be advised that, […]
Important notification
30.05.2024 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]
Important notification
28.05.2024 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]
Important notification
27.05.2024 To the attention of interested persons The Commission Implementation Decision of 24.05.2024 concerning, within the framework of Article 31 […]
Important notification
20.05.2024 To the attention of applicants and Marketing Authorisation Holders of medicinal products for human use Following the publication of […]
Press release
16.05.2024 To the attention of interested persons Hydroxyprogesterone caproate medicines to be suspended from the EU market. Medicinal products containing […]